Revonto Injection, Powder, Lyophilized, For Solution
Product Images NDC 84549-003

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Revonto (NDC 84549-003). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Propharma Distribution, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (84549 003 67)

Label for Revonto IV Solution 20 mg/vial, an injection USP in a 65 mL vial for intravenous use only. The label instructs to protect the vial from direct light and use within 6 hours after reconstitution. Storage is recommended between 20°C to 25°C (68°F to 77°F). Packaged by ProPharma Distribution LLC. NDC 84549-003-67 is partially visible along with lot and expiration date placeholders.*

FDA Label Image

Chemical Structure (Revonto 01)

Chemical structure of dantrolene sodium, the active ingredient in Revonto. The diagram shows the molecular framework including nitrobenzene, furan, and hydantoin components with sodium salt.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.